China NT Pharma Group Company Limited
HKSE: 1011.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Bozhi Zhang
- Employees
- 22
- Headquarters
- Suzhou, China
- IPO year
- 2011
- Market cap
- HK$413.6M
- Website
- https://www.ntpharma.com
Loading 1011…
Loading profile data…Frequently asked questions about 1011
What does China NT Pharma Group Company Limited (1011.HK) do?
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive sy...
Where does 1011.HK trade?
China NT Pharma Group Company Limited (1011.HK) trades on the Hong Kong Stock Exchange.
What sector is 1011.HK in?
China NT Pharma Group Company Limited (1011.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of China NT Pharma Group Company Limited?
Bozhi Zhang is the chief executive officer of China NT Pharma Group Company Limited (1011.HK).
Where is China NT Pharma Group Company Limited headquartered?
China NT Pharma Group Company Limited is headquartered in China.
Does 1011.HK pay a dividend?
China NT Pharma Group Company Limited (1011.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1011.HK go public?
China NT Pharma Group Company Limited (1011.HK) completed its initial public offering in 2011.